The analgesic efficacy of Quadratus lumborum block after colon cancer surgery

The analgesic efficacy of Quadratus lumborum block after colon cancer surgery: a prospective randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002247

Enrollment

Registered

2017-02-28

Start date

2017-02-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : General anesthesia is performed in all patients. And they are randomly assigned to two groups. In the quadratus lumborum block (QLB) group, the patients receive intravenous patient

ropipivacaine 20ml with epinephrine 1: 200000 per one side, total volume 40ml). In the control group, the patients only receive Intravenous PCA without QLB. The pain score and opioid consumption wil

ropivacaine with epinephrine 1: 200000 was injected. Ultrasound: (WS80A, Samsung Medicine, Korea) Local anesthetic: QLB - 0.375 &#37

Ropivacaine 20ml with epinephrine 1: 200000 per one side, both total volume 40ml (Naropin®, AstraZeneca, UK) PCA regimen: no continuous infusion, total fentanyl 20 mcg/kg, total volume 100 ml, bolu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American society of anesthesiology (ASA) physical status 1, 2, 3 male/female Age: 19-80 yrs Patients undergoing colon cancer surgery

Exclusion criteria

Exclusion criteria: Clinically significant coagulopathy Infection at the injection site Allergy to local anesthetics Severe cardiopulmonary disease(American society of anesthesiology (ASA) physical status =4) Body mass index > 35 Diabetic or other neuropathies Patients receiving opioids for chronic analgesic therapy Patients who have refused intravenous patient controlled analgesia (PCA) Inability to comprehend visual analogue scale (VAS) score and patient controlled analgesia (PCA) device Patient who does not want to receive quadratus lumborum block Patients who want to receive a quadratus lumborum block

Design outcomes

Primary

Measure	Time frame
Amount of opioid consumption	—

Secondary

Measure	Time frame
Postoperative pain	—

Countries

Korea, Republic of

Contacts

Public ContactSeunguk Bang

The Catholic University of Korea, Daejeon St. Mary's Hospital

seungukb@naver.com+82-42-220-9046

Outcome results